MT-501

· Mirador Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-501, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Single and Multiple Ascending Dose Study of MT-501 [Phase 1]